The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders

Abstract

The serine/threonine p21-activated kinases (PAKs), as main effectors of the Rho GTPases Cdc42 and Rac, represent a group of important molecular switches linking the complex cytoskeletal networks to broad neural activity. PAKs show wide expression in the brain, but they differ in specific cell types, brain regions, and developmental stages. PAKs play an essential and differential role in controlling neural cytoskeletal remodeling and are related to the development and fate of neurons as well as the structural and functional plasticity of dendritic spines. PAK-mediated actin signaling and interacting functional networks represent a common pathway frequently affected in multiple neurodevelopmental and neurodegenerative disorders. Considering specific small-molecule agonists and inhibitors for PAKs have been developed in cancer treatment, comprehensive knowledge about the role of PAKs in neural cytoskeletal remodeling will promote our understanding of the complex mechanisms underlying neurological diseases, which may also represent potential therapeutic targets of these diseases.

Key words： p21-activated kinases; expression pattern; synaptic cytoskeletal remodeling; neuronal function; neurological diseases

References

1 Allen KM, Gleeson JG, Bagrodia S, Partington MW, MacMillan JC, Cerione RA, Mulley JC, Walsh CA (1998) PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 20:25–30

2 Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P (1998) Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805–809

3 Arias-Romero LE, Chernoff J (2008) A tale of two Paks. Biol Cell 100:97–108

4 Arsenault D, Dal-Pan A, Tremblay C, Bennett DA, Guitton MJ, De Koninck Y, Tonegawa S, Calon F (2013) PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and Abeta. J Neurosci 33:10729–10740

5 Asrar S, Meng Y, Zhou Z, Todorovski Z, Huang WW, Jia Z (2009) Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1). Neuropharmacology 56:73–80

6 Aston C, Jiang L, Sokolov BP (2005) Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry. 10:309–322

7 Banko MR, Allen JJ, Schaffer BE, Wilker EW, Tsou P, White JL, Villén J, Wang B, Kim SR, Sakamoto K (2011) Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis. Mol Cell 44:878–892

8 Barton B, North K (2004) Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol 46:553–563

9 Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E (2012) Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron 76:325–337

10 Bienvenu T, des Portes V, McDonell N, Carrié A, Zemni R, Couvert P, Ropers HH, Moraine C, van Bokhoven H, Fryns JP (2000) Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet 93:294–298

11 Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, Kajiwara Y, Yang M, Katz AM, Scattoni ML (2010) Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism 1:15

12 Brown MD, Cornejo BJ, Kuhn TB, Bamburg JR (2000) Cdc42 stimulates neurite outgrowth and formation of growth cone filopodia and lamellipodia. J Neurobiol 43:352–364

13 Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868

14 Byrne KM, Monsefi N, Dawson JC, Degasperi A, Bukowski-Wills JC, Volinsky N, Dobrzynski M, Birtwistle MR, Tsyganov MA, Kiyatkin A (2016) Bistability in the Rac1, PAK, and RhoA Signaling Network Drives Actin Cytoskeleton Dynamics and Cell Motility Switches. Cell Syst. 2:38–48

15 Causeret F, Terao M, Jacobs T, Nishimura YV, Yanagawa Y, Obata K, Hoshino M, Nikolic M (2009) The p21-activated kinase is required for neuronal migration in the cerebral cortex. Cereb Cortex 19:861–875

16 Chen LY, Rex CS, Babayan AH, Kramár EA, Lynch G, Gall CM, Lauterborn JC (2010) Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J Neurosci 30:10977–10984

17 Chen Q, Chen TJ, Letourneau PC, Costa Lda F, Schubert D (2005) Modifier of cell adhesion regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth. J Neurosci 25:281–290

18 Chen Q, Peto CA, Shelton GD, Mizisin A, Sawchenko PE, Schubert D (2009) Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration. J Neurosci 29:118–130

19 Chen SY, Huang PH, Cheng HJ (2011) Disrupted-in-Schizophrenia 1-mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signaling. Proc Natl Acad Sci U S A. 108:5861–5866

20 Chenette EJ, Mitin NY, Der CJ (2006) Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity. Mol Biol Cell 17:3108–3121

21 Civiero L, Cirnaru MD, Beilina A, Rodella U, Russo I, Belluzzi E, Lobbestael E, Reyniers L, Hondhamuni G, Lewis PA (2015) Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain. J Neurochem 135:1242–1256

22 Cobos I, Borello U, Rubenstein JL (2007) Dlx transcription factors promote migration through repression of axon and dendrite growth. Neuron 54:873–888

23 Cooper JA (2013) Cell biology in neuroscience: mechanisms of cell migration in the nervous system. J Cell Biol 202:725–734

24 Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ (2002) Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415:526–530

25 Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, Parada LF, Mody I, Silva AJ (2008) Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135:549–560

26 Dai X, Iwasaki H, Watanabe M, Okabe S (2014) Dlx1 transcription factor regulates dendritic growth and postsynaptic differentiation through inhibition of neuropilin-2 and PAK3 expression. Eur J Neurosci 39:531–547

27 Daniels RH, Bokoch GM (1999) p21-activated protein kinase: a crucial component of morphological signaling? Trends Biochem Sci 24:350–355

28 Darnell JC, Klann E (2013) The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci 16:1530–1536

29 Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247–261

30 Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39:889–909

31 de la Torre-Ubieta L, Gaudilliere B, Yang Y, Ikeuchi Y, Yamada T, DiBacco S, Stegmuller J, Schuller U, Salih DA, Rowitch D (2010) A FOXO-Pak1 transcriptional pathway controls neuronal polarity. Genes Dev 24:799–813

32 de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH (2016) Advancing the understanding of autism disease mechanisms through genetics. Nat Med 22:345–361

33 Dolan BM, Duron SG, Campbell DA, Vollrath B, Shankaranarayana Rao BS, Ko HY, Lin GG, Govindarajan A, Choi SY, Tonegawa S (2013) Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc Natl Acad Sci U S A. 110:5671–5676

34 Dong X, Liao Z, Gritsch D, Hadzhiev Y (2018) Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nat Neurosci 21:1482–1492

35 Duarte K, Heide S, Poea-Guyon S, Rousseau V, Depienne C, Rastetter A, Nava C, Attie-Bitach T, Razavi F, Martinovic J (2020) PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration. Neurobiol Dis 136:104709

36 Dubos A, Combeau G, Bernardinelli Y, Barnier JV, Hartley O, Gaertner H, Boda B, Muller D (2012) Alteration of synaptic network dynamics by the intellectual disability protein PAK3. J Neurosci 32:519–527

37 Duffney LJ, Wei J, Cheng J, Liu W, Smith KR, Kittler JT, Yan Z (2013) Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism. J Neurosci 33:15767–15778

38 Eswaran J, Soundararajan M, Kumar R, Knapp S (2008) UnPAKing the class differences among p21-activated kinases. Trends Biochem Sci 33:394–403

39 Feng J, Chen S, Wang Y, Liu Q, Yang M, Li X, Nie C, Qin J, Chen H, Yuan X (2019) Maternal exposure to cadmium impairs cognitive development of male offspring by targeting the Coronin1a signaling pathway. Chemosphere 225:765–774

40 Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, Georgieva L, Rees E, Palta P, Ruderfer DM (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506:179–184

41 Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, Fukata M (2006) Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313:1792–1795

42 Gao J, Ha BH, Lou HJ, Morse EM, Zhang R, Calderwood DA, Turk BE, Boggon TJ (2013) Substrate and inhibitor specificity of the type II p21-activated kinase, PAK6. PLoS ONE 8:e77818

43 Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, Huson SM (2013) Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics 132:e1642–e1648

44 Gedeon AK, Nelson J, Gécz J, Mulley JC (2003) X-linked mild nonsyndromic mental retardation with neuropsychiatric problems and the missense mutation A365E in PAK3. Am J Med Genet A 120a:509–517

45 Glantz LA, Lewis DA (2001) Dendritic spine density in schizophrenia and depression. Arch Gen Psychiatry 58:203

46 Gottle P, Sabo JK, Heinen A, Venables G, Torres K (2015) Oligodendroglial maturation is dependent on intracellular protein shuttling. J Neurosci 35:906–919

47 Gotz M, Barde YA (2005) Radial glial cells defined and major intermediates between embryonic stem cells and CNS neurons. Neuron 46:369–372

48 Gu Z, Cheng J, Zhong P, Qin L, Liu W, Yan Z (2014) Abeta selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: implication in Alzheimer’s disease. J Neurosci 34:13614–13628

49 Guo D, Tan YC, Wang D, Madhusoodanan KS, Zheng Y, Maack T, Zhang JJ, Huang XY (2007) A Rac-cGMP signaling pathway. Cell. 128:341–355

50 Ha BH, Boggon TJ (2018) CDC42 binds PAK4 via an extended GTPase-effector interface. Proc Natl Acad Sci U S A. 115:531–536

51 Ha BH, Davis MJ, Chen C, Lou HJ, Gao J, Zhang R, Krauthammer M, Halaban R, Schlessinger J, Turk BE (2012) Type II p21activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate. Proc Natl Acad Sci U S A. 109:16107–16112

52 Harms FL, Kloth K, Bley A, Denecke J, Santer R, Lessel D, Hempel M, Kutsche K (2018) Activating Mutations in PAK1, Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental Disorder. Am J Hum Genet 103:579–591

53 Hayashi-Takagi A, Araki Y, Nakamura M, Vollrath B, Duron SG, Yan Z, Kasai H, Huganir RL, Campbell DA, Sawa A (2014) PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence. Proc Natl Acad Sci U S A. 111:6461–6466

54 Hayashi ML, Choi SY, Rao BS, Jung HY, Lee HK, Zhang D, Chattarji S, Kirkwood A, Tonegawa S (2004) Altered cortical synaptic morphology and impaired memory consolidation in forebrainspecific dominant-negative PAK transgenic mice. Neuron 42:773–787

55 Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S (2007) Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci U S A. 104:11489–11494

56 Henderson ST, Johnson TE (2001) daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol 11:1975–1980

57 Hing H, Xiao J, Harden N, Lim L, Zipursky SL (1999) Pak functions downstream of Dock to regulate photoreceptor axon guidance in Drosophila. Cell 97:853–863

58 Hoekman MF, Jacobs FM, Smidt MP, Burbach JP (2006) Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr Patterns 6:134–140

59 Horn S, Au M, Basel-Salmon L, Bayrak-Toydemir P, Chapin A, Cohen L, Elting MW, Graham JM, Gonzaga-Jauregui C, Konen O (2019) De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures. Brain 142:3351–3359

60 Hu B, Arpag S, Zhang X, Möbius W, Werner H, Sosinsky G, Ellisman M, Zhang Y, Hamilton A, Chernoff J (2016) Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP. PLoS Genet 12:e1006290

61 Huang W, Zhou Z, Asrar S, Henkelman M, Xie W, Jia Z (2011) p21Activated kinases 1 and 3 control brain size through coordinating neuronal complexity and synaptic properties. Mol Cell Biol 31:388–403

62 Huijbregts S, Jahja R, De Sonneville L, de Breij S, Swaab-Barneveld H (2010) Social information processing in children and adolescents with neurofibromatosis type 1. Dev Med Child Neurol 52:620–625

63 Huijbregts SC, de Sonneville LM (2011) Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1? Behav Genet 41:430–436

64 Hussain NK, Thomas GM, Luo J, Huganir RL (2015) Regulation of AMPA receptor subunit GluA1 surface expression by PAK3 phosphorylation. Proc Natl Acad Sci U S A. 112:E5883–E5890

65 Jacobs T, Causeret F, Nishimura YV, Terao M, Norman A, Hoshino M, Nikolic M (2007) Localized activation of p21-activated kinase controls neuronal polarity and morphology. J Neurosci 27:8604–8615

66 Jaffer ZM, Chernoff J (2002) p21-activated kinases: three more join the Pak. Int J Biochem Cell Biol 34:713–717

67 Jan YN, Jan LY (2003) The control of dendrite development. Neuron 40:229–242

68 Johnson MB, Kawasawa YI, Mason CE, Krsnik Z, Coppola G, Bogdanović D, Geschwind DH, Mane SM, State MW, Sestan N (2009) Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 62:494–509

69 Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y, Sawamura N, Park U, Kudo C, Okawa M (2005) A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7:1167–1178

70 Kamiyama D, McGorty R, Kamiyama R, Kim MD, Chiba A, Huang B (2015) Specification of Dendritogenesis Site in Drosophila aCC Motoneuron by Membrane Enrichment of Pak1 through Dscam1. Dev Cell 35:93–106

71 Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G (2011) Spatio-temporal transcriptome of the human brain. Nature 478:483–489

72 Kennedy LM, Pham SC, Grishok A (2013) Nonautonomous regulation of neuronal migration by insulin signaling, DAF-16/FOXO, and PAK-1. Cell Rep. 4:996–1009

73 Kim MJ, Biag J, Fass DM, Lewis MC, Zhang Q, Fleishman M, Gangwar SP, Machius M, Fromer M, Purcell SM (2017) Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity. Mol Psychiatry. 22:417–429

74 Knaus UG, Bokoch GM (1998) The p21Rac/Cdc42-activated kinases (PAKs). Int J Biochem Cell Biol 30:857–862

75 Kong D, Dagon Y, Campbell JN, Guo Y, Yang Z, Yi X, Aryal P, Wellenstein K, Kahn BB, Sabatini BL (2016) A Postsynaptic AMPK→p21-Activated Kinase Pathway Drives Fasting-Induced Synaptic Plasticity in AgRP Neurons. Neuron 91:25–33

76 Kreis P, Barnier JV (2009) PAK signalling in neuronal physiology. Cell Signal 21:384–393

77 Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, Egan DA, Ketema M, van den Nieuwendijk R, van den Eeden SJ, Geluk A (2007) Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450:725–730

78 Lamoureux P, Altun-Gultekin ZF, Lin C, Wagner JA, Heidemann SR (1997) Rac is required for growth cone function but not neurite assembly. J Cell Sci 110(Pt 5):635–641

79 Lauterborn JC, Cox CD, Chan SW, Vanderklish PW, Lynch G, Gall CM (2020) Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease. Brain Pathol 30:319–331

80 Lee RY, Hench J, Ruvkun G (2001) Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr Biol 11:1950–1957

81 Lehtonen A, Howie E, Trump D, Huson SM (2013) Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol 55:111–125

82 Lei M, Lu W, Meng W, Parrini MC, Eck MJ, Mayer BJ, Harrison SC (2000) Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 102:387–397

83 Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168–176

84 Leung C, Cao F, Nguyen R, Joshi K, Aqrabawi AJ, Xia S, Cortez MA, Snead OC 3rd, Kim JC, Jia Z (2018) Activation of Entorhinal Cortical Projections to the Dentate Gyrus Underlies Social Memory Retrieval. Cell Rep. 23:2379–2391

85 Lewis DA, Glantz LA, Pierri JN, Sweet RA (2003) Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons. Ann N Y Acad Sci 1003:102–112

86 Lewis DA, Levitt P (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25:409–432

87 Li S, Leshchyns’ka I, Chernyshova Y, Schachner M, Sytnyk V (2013) The neural cell adhesion molecule (NCAM) associates with and signals through p21-activated kinase 1 (Pak1). J Neurosci 33:790–803

88 Lin K, Hsin H, Libina N, Kenyon C (2001) Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF1 and germline signaling. Nat Genet 28:139–145

89 Liu J, Liu Y, Shao J, Li Y, Qin L, Shen H, Xie Y, Xia W (2019) Zeb1 is important for proper cleavage plane orientation of dividing progenitors and neuronal migration in the mouse neocortex. Cell Death Differ 26:2479–2492

90 Lucanic M, Kiley M, Ashcroft N, L’Etoile N, Cheng HJ (2006) The Caenorhabditis elegans P21-activated kinases are differentially required for UNC-6/netrin-mediated commissural motor axon guidance. Development. 133:4549–4559

91 Ma QL, Yang F, Calon F, Ubeda OJ, Hansen JE, Weisbart RH, Beech W, Frautschy SA, Cole GM (2008) p21-activated kinaseaberrant activation and translocation in Alzheimer disease pathogenesis. J Biol Chem 283:14132–14143

92 Maglorius Renkilaraj MRL, Baudouin L, Wells CM, Doulazmi M, Wehrle R, Cannaya V, Bachelin C, Barnier JV, Jia Z, Nait Oumesmar B (2017) The intellectual disability protein PAK3 regulates oligodendrocyte precursor cell differentiation. Neurobiol Dis 98:137–148

93 Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L (1994) A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367:40–46

94 Marin O, Valiente M, Ge X, Tsai LH (2010) Guiding neuronal cell migrations. Cold Spring Harb Perspect Biol. 2:a001834

95 Martini FJ, Valiente M, Lopez Bendito G, Szabo G, Moya F, Valdeolmillos M, Marin O (2009) Biased selection of leading process branches mediates chemotaxis during tangential neuronal migration. Development. 136:41–50

96 Meng J, Meng Y, Hanna A, Janus C, Jia Z (2005) Abnormal longlasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J Neurosci 25:6641–6650

97 Molosh AI, Johnson PL, Spence JP, Arendt D, Federici LM, Bernabe C, Janasik SP, Segu ZM, Khanna R, Goswami C (2014) Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. Nat Neurosci 17:1583–1590

98 Murata Y, Constantine-Paton M (2013) Postsynaptic density scaffold SAP102 regulates cortical synapse development through EphB and PAK signaling pathway. J Neurosci 33:5040–5052

99 Nakai Y, Zheng Y, MacCollin M, Ratner N (2006) Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells. J Neurosci 26:3390–3395

100 Nekrasova T, Jobes ML, Ting JH, Wagner GC, Minden A (2008) Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion. Dev Biol 322:95–108

101 Nguyen TV, Galvan V, Huang W, Banwait S, Tang H, Zhang J, Bredesen DE (2008) Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem 104:1065–1080

102 Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai LH (1998) The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 395:194–198

103 Nobes CD, Hall A (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53–62

104 Nobes CD, Hall A (1999) Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144:1235–1244

105 Noll RB, Reiter-Purtill J, Moore BD, Schorry EK, Lovel AM, Vannatta K, Gerhardt CA (2007) Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet A 143a:2261–2273

106 O’Donnell M, Chance RK, Bashaw GJ (2009) Axon growth and guidance: receptor regulation and signal transduction. Annu Rev Neurosci 32:383–412

107 O’Donnell WT, Warren ST (2002) A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 25:315–338

108 Parrini MC, Camonis J, Matsuda M, de Gunzburg J (2009) Dissecting activation of the PAK1 kinase at protrusions in living cells. J Biol Chem 284:24133–24143

109 Parrini MC, Lei M, Harrison SC, Mayer BJ (2002) Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1. Mol Cell 9:73–83

110 Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G (2011) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472:437–442

111 Peippo M, Koivisto AM, Särkämö T, Sipponen M, von Koskull H, Ylisaukko-oja T, Rehnström K, Froyen G, Ignatius J, Järvelä I (2007) PAK3 related mental disability: further characterization of the phenotype. Am J Med Genet A 143a:2406–2416

112 Pensold D, Symmank J, Hahn A, Lingner T, Salinas-Riester G, Downie BR, Ludewig F, Rotzsch A, Haag N, Andreas N (2017) The DNA Methyltransferase 1 (DNMT1) Controls the Shape and Dynamics of Migrating POA-Derived Interneurons Fated for the Murine Cerebral Cortex. Cereb Cortex 27:5696–5714

113 Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, Mains RE, Huganir RL (2003) Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron 37:263–274

114 Pereanu W, Larsen EC, Das I, Estevez MA, Sarkar AA, SpringPearson S, Kollu R, Basu SN, Banerjee-Basu S (2018) AutDB: a platform to decode the genetic architecture of autism. Nucleic Acids Res 46:D1049–D1054

115 Pirruccello M, Sondermann H, Pelton JG, Pellicena P, Hoelz A, Chernoff J, Wemmer DE, Kuriyan J (2006) A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases. J Mol Biol 361:312–326

116 Pletikos M, Sousa AM, Sedmak G, Meyer KA, Zhu Y, Cheng F, Li M, Kawasawa YI, Sestan N (2014) Temporal specification and bilaterality of human neocortical topographic gene expression. Neuron 81:321–332

117 Pride NA, Korgaonkar MS, Barton B, Payne JM, Vucic S, North KN (2014) The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1. Hum Brain Mapp 35:2372–2382

118 Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O’Dushlaine C, Chambert K, Bergen SE, Kahler A (2014) A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506:185–190

119 Pyronneau A, He Q, Hwang JY (2017) Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome. Sci Signal 10eaan0852

120 Qu J, Li X, Novitch BG, Zheng Y, Kohn M, Xie JM, Kozinn S, Bronson R, Beg AA, Minden A (2003) PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol Cell Biol 23:7122–7133

121 Quintero-Rivera F, Sharifi-Hannauer P, Martinez-Agosto JA (2010) Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review. Am J Med Genet A 152a:2459–2467

122 Radu M, Semenova G, Kosoff R, Chernoff J (2014) PAK signalling during the development and progression of cancer. Nat Rev Cancer 14:13–25

123 Ramos CI, Igiesuorobo O, Wang Q, Serpe M (2015) Neto-mediated intracellular interactions shape postsynaptic composition at the Drosophila neuromuscular junction. PLoS Genet 11:e1005191

124 Rane CK, Minden A (2014) P21 activated kinases: structure, regulation, and functions. Small GTPases. 5:1–11

125 Rashid T, Banerjee M, Nikolic M (2001) Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J Biol Chem 276:49043–49052

126 Rejeb I, Saillour Y, Castelnau L, Julien C, Bienvenu T, Taga P, Chaabouni H, Chelly J, Ben Jemaa L, Bahi-Buisson N (2008) A novel splice mutation in PAK3 gene underlying mental retardation with neuropsychiatric features. Eur J Hum Genet 16:1358–1363

127 Richier L, Williton K, Clattenburg L, Colwill K, O’Brien M, Tsang C, Kolar A, Zinck N, Metalnikov P, Trimble WS (2010) NOS1AP associates with Scribble and regulates dendritic spine develop-ment. J Neurosci 30:4796–4805

128 Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52:139–153

129 Rubio MD, Haroutunian V, Meador-Woodruff JH (2012) Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia. Biol Psychiatry 71:906–914

130 Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P (1999) Inhibition of myosin light chain kinase by p21-activated kinase. Science 283:2083–2085

131 Santini E, Huynh TN, Longo F, Koo SY, Mojica E, Anderson MJ, Bagni C, Klann E (2017) Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice. Science Signaling 10:eaan0665

132 Sells MA, Chernoff J (1997) Emerging from the Pak: the p21activated protein kinase family. Trends Cell Biol 7:162–167

133 Sivanesan S, Tan A, Rajadas J (2013) Pathogenesis of Abeta oligomers in synaptic failure. Curr Alzheimer Res 10:316–323

134 Smith KR, Davenport EC, Wei J, Li X, Pathania M, Vaccaro V, Yan Z, Kittler JT (2014) GIT1 and βPIX are essential for GABA (A) receptor synaptic stability and inhibitory neurotransmission. Cell Rep. 9:298–310

135 Souopgui J, Solter M, Pieler T (2002) XPak3 promotes cell cycle withdrawal during primary neurogenesis in Xenopus laevis. EMBO J 21:6429–6439

136 Strochlic TI, Concilio S, Viaud J, Eberwine RA, Wong LE, Minden A, Turk BE, Plomann M, Peterson JR (2012) Identification of neuronal substrates implicates Pak5 in synaptic vesicle trafficking. Proc Natl Acad Sci U S A. 109:4116–4121

137 Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187–1192

138 Tabanifar B, Zhao Z, Manser E (2016) PAK5 is auto-activated by a central domain that promotes kinase oligomerization. Biochem J. 473:1777–1789

139 Tyagi N, Bhardwaj A, Singh AP, McClellan S, Carter JE, Singh S (2014) p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKTand ERK-dependent activation of NF-κB pathway. Oncotarget. 5:8778–8789

140 Udo H, Jin I, Kim JH, Li HL, Youn T, Hawkins RD, Kandel ER, Bailey CH (2005) Serotonin-induced regulation of the actin network for learning-related synaptic growth requires Cdc42, N-WASP, and PAK in Aplysia sensory neurons. Neuron 45:887–901

141 Walsh KS, Velez JI, Kardel PG, Imas DM, Muenke M, Packer RJ, Castellanos FX, Acosta MT (2013) Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol 55:131–138

142 Wang W, Lim L, Baskaran Y, Manser E, Song J (2013) NMR binding and crystal structure reveal that intrinsically-unstructured regulatory domain auto-inhibits PAK4 by a mechanism different from that of PAK1. Biochem Biophys Res Commun 438:169–174

143 Wang Y, Zeng C, Li J, Zhou Z, Ju X, Xia S, Li Y, Liu A, Teng H, Zhang K (2018) PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior. Cell Rep. 24:2029–2041

144 Willatt L, Cox J, Barber J, Cabanas ED, Collins A, Donnai D, FitzPatrick DR, Maher E, Martin H, Parnau J (2005) 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 77:154–160

145 Won SY, Park MH, You ST, Choi SW, Kim HK, McLean C, Bae SC, Kim SR, Jin BK, Lee KH (2016) Nigral dopaminergic PAK4 prevents neurodegeneration in rat models of Parkinson's disease. Sci Transl Med 8:367ra170

146 Xia S, Zhou Z, Leung C, Zhu Y, Pan X, Qi J, Morena M, Hill MN, Xie W, Jia Z (2016) p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus. eLife 14:e14653

147 Yan Z, Kim E, Datta D, Lewis DA, Soderling SH (2016) Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders? J Neurosci 36:11411–11417

148 Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K (1998) Cofilin phosphorylation by LIMkinase 1 and its role in Rac-mediated actin reorganization. Nature 393:809–812

149 Yasui H, Katoh H, Yamaguchi Y, Aoki J, Fujita H, Mori K, Negishi M (2001) Differential responses to nerve growth factor and epidermal growth factor in neurite outgrowth of PC12 cells are determined by Rac1 activation systems. J Biol Chem 276:15298–15305

150 Zeisel A, Hochgerner H, Lönnerberg P, Johnsson A, Memic F, van der Zwan J, Häring M, Braun E, Borm LE, La Manno G (2018) Molecular Architecture of the Mouse Nervous System. Cell 174:999–1014.e1022

151 Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci 9:234–242

152 Zhong JL, Banerjee MD, Nikolic M (2003) Pak1 and its T212 phosphorylated form accumulate in neurones and epithelial cells of the developing rodent. Dev Dyn 228:121–127